GS Julian
GS Julian publishes mostly in Economics and Econometrics, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, on topics such as Health Systems, Economic Evaluations, Quality of Life, Public Health in Brazil and Lung Cancer Treatments and Mutations.
- World rank
- #6,262,325 of 7,710,434 ranked researchers
- Rank in Brazil
- #160,935 of 253,246
- Works
- 16
- Citations
- 6
- Citations per work
- 0.4
What does GS Julian research?
GS Julian's work is mostly in Medicine (34%), Economics, Econometrics and Finance (20%), Social Sciences (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Social Sciences636.6%
- Health Sciences534.1%
- Medicine534.1%
- Everything else529.3%
- 1Economics and Econometrics20% of their works
- 2Pulmonary and Respiratory Medicine15% of their works
- 3Public Health, Environmental and Occupational Health12% of their works
- 4Sociology and Political Science12% of their works
- 5Oncology7% of their works
- 6Organizational Behavior and Human Resource Management5% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Public Health in Brazil
- Lung Cancer Treatments and Mutations
- Economic and Financial Impacts of Cancer
- Cancer Genomics and Diagnostics
- Global Public Health Policies and Epidemiology
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Health, Environment, Cognitive Aging
Which keywords describe GS Julian's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Healthcare Access, Judicialization, Quality of Life, Targeted Therapy, ALK Inhibitors, Cost of Care and EGFR Mutations.
- Exposome
- Cardiac Amyloidosis
- Mutational Signatures
- Cancer Genomics
- EGFR Mutations
- ALK Inhibitors
- Quality of Life
- Healthcare Access
- Cost-effectiveness Analysis
- Judicialization
- Targeted Therapy
- Cost of Care
- Financial Toxicity
- Corporate Political Activity
- Non-Communicable Diseases
- Environmental Exposure
- Transthyretin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Cost-effectiveness Analysis51 topic
- Healthcare Access51 topic
- Judicialization51 topic
- Quality of Life51 topic
- Targeted Therapy52 topics
- ALK Inhibitors31 topic
- Cost of Care31 topic
- EGFR Mutations31 topic
- Financial Toxicity31 topic
- Cancer Genomics21 topic
- Corporate Political Activity21 topic
- Mutational Signatures21 topic
- Non-Communicable Diseases21 topic
- Cardiac Amyloidosis11 topic
- Environmental Exposure11 topic
- Exposome11 topic
- Transthyretin11 topic
Where does GS Julian work?
GS Julian's main affiliation in the publication record is Kantar Health (Brazil), Brazil.
How many publications and citations does GS Julian have?
OpenAlex counts 16 works and 6 citations for GS Julian, an h-index of 1, ranking #6,262,325 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about GS Julian. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.